| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| H3P28 |
|
H3 histone pseudogene 28
|
|
|
0.553 |
0.692 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
| MFT2 |
|
Trichoepithelioma, multiple familial, 2
|
|
|
0.601 |
0.692 |
| CPP |
|
ceruloplasmin pseudogene
|
|
|
0.631 |
0.731 |
| TMED10P1 |
|
transmembrane p24 trafficking protein 10 pseudogene 1
|
|
|
0.663 |
0.615 |
| H3P17 |
|
H3 histone pseudogene 17
|
|
|
0.674 |
0.615 |
| ERICD |
|
E2F1-regulated inhibitor of cell death
|
|
|
0.691 |
0.654 |
| MSD |
|
microcephaly with spastic diplegia (Paine syndrome)
|
|
|
0.674 |
0.654 |
| MIR510 |
|
microRNA 510
|
|
|
0.678 |
0.423 |
| AD12 |
|
Alzheimer disease 12
|
|
|
0.711 |
0.538 |
| ST11 |
|
suppression of tumorigenicity 11 (pancreas)
|
|
|
0.722 |
0.346 |
| DHS |
|
dehydrated hereditary stomatocytosis
|
|
|
0.769 |
0.423 |
| SEC1P |
|
secretory blood group 1, pseudogene
|
|
|
0.792 |
0.385 |
| AFA |
|
ankyloblepharon filiforme adnatum
|
|
|
0.792 |
0.462 |
| HTR3E |
A5X5Y0
|
5-hydroxytryptamine receptor 3E
|
Ion channel
|
4.2E-10 |
0.839 |
0.077 |
| ARHGAP42 |
A6NI28
|
Rho GTPase activating protein 42
|
Enzyme modulator
|
1.00 |
0.792 |
0.385 |